Clinical Trials Directory

Trials / Conditions / Advanced Esophageal Squamous Cell Carcinoma

Advanced Esophageal Squamous Cell Carcinoma

11 registered clinical trials studyying Advanced Esophageal Squamous Cell Carcinoma — 9 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metasta
NCT07487896
MediLink Therapeutics (Suzhou) Co., Ltd.Phase 3
Not Yet RecruitingA Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal S
NCT07484724
Shanghai Junshi Bioscience Co., Ltd.Phase 2
Not Yet RecruitingA Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squ
NCT07446335
The First Affiliated Hospital of Zhengzhou UniversityPhase 3
Not Yet RecruitingStudy of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caic
NCT07469241
Fudan UniversityPhase 2
RecruitingAK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Pa
NCT06489197
Tianjin Medical University Cancer Institute and HospitalPhase 2
RecruitingComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected
NCT06265285
Mayo ClinicPhase 2
RecruitingA Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma
NCT06512428
Shanghai Runshi Pharmaceutical Technology Co., LtdPhase 2
RecruitingA Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell
NCT05910827
Hummingbird BiosciencePhase 1 / Phase 2
TerminatedClinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With
NCT05834543
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 / Phase 2
UnknownTo Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC
NCT05818982
Peking UniversityPhase 2
RecruitingPenpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcin
NCT05214222
Nanfang Hospital, Southern Medical UniversityPhase 2